Lineage Cell Therapeutics, Inc. Common Stock (NY:LCTX)

0.9301 +0.0001 (+0.01%)

Delayed Quote Updated: 10:08 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lineage Cell Therapeutics, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Lineage Cell Stock Jumps as OpRegen Shows Additional Cases Of Retinal Tissue Restoration In Mid-Stage Study ↗

June 01, 2021

Lineage Cell Therapeutics Inc (NYSE: LCTX) has announced that restoration of retinal tissue was observed in two additional patients enrolled in the Phase 1/2a...

Via Benzinga

Lineage Cell Therapeutics Reports Additional Cases of Retinal Tissue Restoration in Dry AMD Patients Treated With OpRegen® RPE Cells

June 01, 2021

From Lineage Cell Therapeutics, Inc.

Via Business Wire

Lineage Cell Therapeutics, Inc. (LCTX) Q1 2021 Earnings Call Transcript ↗

May 14, 2021

LCTX earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Lineage Reports First Quarter 2021 Financial Results and Highlights Significant Progress With All Three Clinical Programs

May 13, 2021

From Lineage Cell Therapeutics, Inc.

Via Business Wire

Lineage Announces Appointment of Anula Jayasuriya, M.D., PH.D., M.B.A., to Board of Directors

May 05, 2021

From Lineage Cell Therapeutics, Inc.

Via Business Wire

The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use ↗

May 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc...

Via Benzinga

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

Lineage Cell Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update on May 13, 2021

May 04, 2021

From Lineage Cell Therapeutics, Inc.

Via Business Wire

Lineage Cell's Dry Age-Related Macular Degeneration Cell Therapy Associated With Stable Or Improved Vision ↗

May 03, 2021

Lineage Cell Therapeutics Inc (NYSE: LCTX) has updated interim results from its ongoing Phase 1/2a study of its lead product candidate, OpRegen, for dry age-...

Via Benzinga

OpRegen® Clinical Data Continues to Demonstrate Improvements in Patients With Dry AMD With Geographic Atrophy

May 03, 2021

From Lineage Cell Therapeutics, Inc.

Via Business Wire

Lineage to Present at the B. Riley Securities’ Neuroscience Conference on April 28, 2021

April 26, 2021

From Lineage Cell Therapeutics, Inc.

Via Business Wire

The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx ↗

April 24, 2021

Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...

Via Benzinga

Lineage Announces Appointment of Dr. Dipti Amin to Its Board of Directors

April 22, 2021

From Lineage Cell Therapeutics, Inc.

Via Business Wire

Why Lineage Cell Therapeutics Stock Popped Today ↗

April 20, 2021

The company announced a license agreement.

Via The Motley Fool

Lineage Stock Gains After Licensing Pact With Immunomic Therapeutics For Cancer Immunotherapy Platform ↗

April 20, 2021

Lineage Cell Therapeutics Inc (NYSE: LCTX) has entered into a worldwide license and development collaboration agreement with a privately-held Immunomic...

Via Benzinga

Lineage Announces Worldwide License Agreement With Immunomic Therapeutics for an Allogeneic Cell-Based Cancer Immunotherapy Based on Its VAC Platform

April 20, 2021

From Lineage Cell Therapeutics, Inc.

Via Business Wire

OpRegen® Data Update to Be Featured at 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Presentation by Christopher D. Riemann, MD

April 12, 2021

From Lineage Cell Therapeutics, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.